M923

· Momenta Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for M923, covering 2018-05-01 to 2018-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of M923 and Humira® in Subjects With Chronic Plaque-type Psoriasis [Phase 3]